US 8920799
Methods of treating cancer by administering an Axl ligand-binding portion of an Axl tyrosine kinase receptor extracellular domain
granted A61PA61P35/00A61P35/02
Quick answer
US patent 8920799 (Methods of treating cancer by administering an Axl ligand-binding portion of an Axl tyrosine kinase receptor extracellular domain) held by The Regents of the University of Colorado, a Body Corporate expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P7/00